Press releasePRNewswire
Coincheck Group N.V.
CNCKW · NASDAQ
$0.18−$0.0147 (−7.55%)TodayMarket closed ·
Prev close $0.1947
CNCKW key statistics
- Market cap
- —
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 435
- Volume
- 4.19K
- Open price
- $0.1551
- High today
- $0.1925
- Low today
- $0.1501
- 52 Week high
- $1.94
- 52 Week low
- $0.123
Coincheck Group N.V. (CNCKW) at a glance
As of Oct 30, 2026, Coincheck Group N.V. (CNCKW) shares are priced at $0.18, giving the company a price-to-earnings ratio of 0.00.
Today the stock has traded between $0.1501 and $0.1925. The current price is 19.9% above the day's low and 6.5% below its high.
Volume so far is 4.19K shares, above the average of 435 shares a day.
Over the past year Coincheck Group N.V. has ranged from $0.123 to $1.94, and now sits 3% of the way up that range.
CNCKW news
Most active stocks
Highest trading volume today
- BURUNuburu$0.287−22.79%
- INTCIntel$65.76−28.58%
- SLGBSmart Logistics Global$0.3051+48.97%
- AXXAExxe Group$0.0006+50.00%
- RDARRaadr$0.0002+0.00%
- SOXLDirexion Shares ETF Trust$77.05−24.75%
- HUBCHub Cyber Security$0.1134−16.00%
- RWAXTAP Real Estate Technologies$0.0002+0.00%
- NVDANVIDIA$204.64−4.20%
- NVDGraniteShares ETF Trust$4.43+8.19%
- SPCXSpace Exploration Technologies$134.69−6.39%
- GTVHGolden Triangle Ventures$0.0001+0.00%
Newly listed
Companies that went public in the past six weeks
- GBCGEORGIA BANKING$38.38+0.27%
- BHAIUBHAV Acquisition Corp II$9.98+0.00%
- SCQCUSPACCircle Acquisition$9.99+0.05%
- LYCALycia Therapeutics$26.40−4.80%
- DAVIDAVION HEALTHCARE$1.68−37.55%
- TCXBTCGX Acquisition Corp. II$10.14−0.66%
- CTYCITY THERAPEUTICS$20.71−6.46%
- IAMIambic Therapeutics$13.43−5.95%
- AMROAmaero$5.56−3.81%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.17−0.39%
- TRXBTRex Bio$13.74+1.63%
- RTSNRetension Pharmaceuticals$11.36−3.97%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.